{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:35:32Z","timestamp":1774596932049,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016305","name":"First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Guanxinning tablet (GXNT), a traditional Chinese medicine preparation, has been found to improve lipid metabolism in patients with cardiovascular disease. However, the underlying mechanisms are still poorly understood. This study aims to determine whether the gut microbiota and bile acid (BA) metabolism is involved in the mechanisms by which GXNT ameliorates hyperlipidemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The chemical composition of GXNT was characterized using UPLC-Q-TOF\/MS. A mouse model of hyperlipidemia was established by feeding an high-fat diet (HFD), and GXNT or simvastatin was administered by gavage for 6 weeks. The impact of GXNT on hyperlipidemia was assessed by measuring markers related to lipid metabolism, liver injury and inflammation. Furthermore, 16S rDNA sequencing, targeted metabolomics, immunohistochemistry, molecular docking and western blot were used to investigate the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GXNT treatment reduced blood lipid levels, improved liver injury, and mitigated hepatic inflammation in HFD-fed mice. GXNT also ameliorated the dysfunction of the intestinal barrier by upregulating the expression of zonula occludens-1 (ZO-1), occludin and claudin-1. Importantly, GXNT remodeled the gut microbiota in mice with hyperlipidemia, which was manifested by an increase in the abundance of Bacteroidota and Rikenellaceae\n                      <jats:italic>_RC9_gut_group<\/jats:italic>\n                      , as well as a decrease in the abundance of\n                      <jats:italic>Desulfovibrio<\/jats:italic>\n                      ,\n                      <jats:italic>Monoglobus<\/jats:italic>\n                      , and\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      . In addition, GXNT intervention altered the composition of fecal BAs and regulated BA metabolism by mediating the hepatic farnesoid X receptor (FXR)\/small heterodimer partner (SHP) and intestinal FXR\/fibroblast growth factor 15 (FGF15) axis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GXNT improved hyperlipidemia by altering the gut microbiota and regulating BA metabolism in HFD-fed mice. Our results provide a theoretical basis for the application of GXNT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1754769","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:38:07Z","timestamp":1774593487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Guanxinning tablet on the gut microbiota and bile acid metabolism in mice with hyperlipidemia"],"prefix":"10.3389","volume":"17","author":[{"given":"Xincun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jama.2023.2307","article-title":"Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to march 2020","volume":"329","author":"Aggarwal","year":"2023","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3748\/wjg.v28.i43.6131","article-title":"Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism","volume":"28","author":"Ai","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"118808","DOI":"10.1016\/j.jep.2024.118808","article-title":"ZiBu PiYin recipe regulates central and peripheral A\u03b2 metabolism and improves diabetes-associated cognitive decline in ZDF rats","volume":"337","author":"Bi","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1073113","DOI":"10.3389\/fcimb.2022.1073113","article-title":"Gut microbiota signature as predictors of adverse outcomes after acute ischemic stroke in patients with hyperlipidemia","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.tjnut.2023.12.047","article-title":"Aromatic amino acids promote lipid metabolism disorders by increasing hepatic bile acid synthesis","volume":"154","author":"Chen","year":"","journal-title":"J. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.2147\/jir.s490896","article-title":"Guanxinning for residual inflammation of stable coronary artery disease: a pilot randomized controlled trial","volume":"17","author":"Chen","year":"","journal-title":"J. Inflamm. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1515364","DOI":"10.3389\/fmicb.2025.1515364","article-title":"Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"103230","DOI":"10.1016\/j.redox.2024.103230","article-title":"\u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1\u03b1\/Nrf2 pathway","volume":"74","author":"Cheng","year":"2024","journal-title":"Redox Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/s0140-6736(22)01545-8","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1039\/d2fo01828d","article-title":"Gougunao tea polysaccharides ameliorate high-fat diet-induced hyperlipidemia and modulate gut microbiota","volume":"14","author":"Deng","year":"2023","journal-title":"Food Funct."},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1194\/jlr.M070888","article-title":"Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters","volume":"58","author":"Dong","year":"2017","journal-title":"J. Lipid Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2317596121","DOI":"10.1073\/pnas.2317596121","article-title":"The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis","volume":"121","author":"Dong","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"G682","DOI":"10.1152\/ajpgi.00386.2018","article-title":"Bile acid treatment and FXR agonism lower postprandial lipemia in mice","volume":"318","author":"Farr","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.3390\/foods13244113","article-title":"Green radish polysaccharides ameliorate Hyperlipidemia in high-fat-diet-induced mice via short-chain fatty acids production and gut Microbiota regulation","volume":"13","author":"Geng","year":"2024","journal-title":"Foods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1439744","DOI":"10.3389\/fcimb.2024.1439744","article-title":"Association of glycerolipid metabolism with gut microbiota disturbances in a hamster model of high-fat diet-induced hyperlipidemia","volume":"14","author":"Han","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e70363","DOI":"10.1096\/fj.202402688R","article-title":"Xuefu Zhuyu Decoction improves hyperlipidemia through the MAPK\/NF-\u03baB and MAPK\/PPAR\u03b1\/CPT-1A signaling pathway","volume":"39","author":"Han","year":"2025","journal-title":"Faseb J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.3892\/mmr.2016.5133","article-title":"Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2\/Pcsk9 signaling pathway in hyperlipidemic rats","volume":"13","author":"Jia","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"136416","DOI":"10.1016\/j.jhazmat.2024.136416","article-title":"Copper oxide nanoparticles induce non-alcoholic fatty liver disease by disrupting bile acid homeostasis and perturbing the intestinal microbial homeostasis","volume":"480","author":"Jiang","year":"2024","journal-title":"J. Hazard Mater"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2300141","DOI":"10.1002\/mnfr.202300141","article-title":"A newly synbiotic combination alleviates obesity by modulating the Gut Microbiota-Fat axis and inhibiting the hepatic TLR4\/NF-\u03baB signaling pathway","volume":"67","author":"Kang","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106570","DOI":"10.1016\/j.phrs.2022.106570","article-title":"Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia","volume":"187","author":"Kappel","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"791614","DOI":"10.3389\/fphar.2021.791614","article-title":"Effects of xylooligosaccharides on lipid metabolism, inflammation, and Gut Microbiota in C57BL\/6J mice Fed a high-fat diet","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijbiomac.2022.06.073","article-title":"Sodium alginate and galactooligosaccharides ameliorate metabolic disorders and alter the composition of the gut microbiota in mice with high-fat diet-induced obesity","volume":"215","author":"Li","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12906-023-04195-2","article-title":"Protective effects of GuanXinNing tablet (GXNT) on diabetic encephalopathy in zucker diabetic obesity (ZDF) rats","volume":"23","author":"Li","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/hep.23463","article-title":"5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice","volume":"51","author":"Mart\u00ednez-Clemente","year":"2010","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e6089","DOI":"10.1002\/bmc.6089","article-title":"Combining 16S rRNA gene sequencing and metabolomics to Study the therapeutic effects of Sangge Jiangzhi Pill on hyperlipidemia rats","volume":"39","author":"Pan","year":"2025","journal-title":"Biomed. Chromatogr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115638","DOI":"10.1016\/j.foodres.2024.115638","article-title":"Non-starch polysaccharides from Castanea mollissima Bl. ameliorate metabolic syndrome by remodeling barrier function, microbial community, and metabolites in high-fat-diet\/streptozotocin-induced diabetic mice","volume":"202","author":"Peng","year":"2025","journal-title":"Food Res. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"117247","DOI":"10.1016\/j.jep.2023.117247","article-title":"Phthalides from the rhizome of Ligusticum chuanxiong Hort. attenuate diabetic nephropathy in mice","volume":"319","author":"Qi","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"116836","DOI":"10.1016\/j.lfs.2019.116836","article-title":"Tetramethylpyrazine prevents diabetes by activating PI3K\/Akt\/GLUT-4 signalling in animal model of type-2 diabetes","volume":"236","author":"Rai","year":"2019","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/metabo15020127","article-title":"Therapeutic strategies to modulate gut microbial health: approaches for chronic Metabolic disorder management","volume":"15","author":"Rondanelli","year":"2025","journal-title":"Metabolites"},{"key":"B34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2337\/db20-0856","article-title":"Defective FXR-SHP regulation in obesity aberrantly increases miR-802 expression, promoting insulin resistance and fatty liver","volume":"70","author":"Seok","year":"2021","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/pharmaceutics16111483","article-title":"Enteric delayed-release granules loading dendrobine ameliorates hyperlipidemia in mice by regulating intestinal flora composition","volume":"16","author":"Song","year":"2024","journal-title":"Pharmaceutics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.7150\/thno.53624","article-title":"Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1039\/d3fo04985j","article-title":"Lacticaseibacillus rhamnosus HF01 fermented yogurt alleviated high-fat diet-induced obesity and hepatic steatosis via the gut microbiota-butyric acid-hepatic lipid metabolism axis","volume":"15","author":"Sun","year":"2024","journal-title":"Food Funct."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1444967","DOI":"10.3389\/fphar.2024.1444967","article-title":"Integrated serum pharmacochemistry, pharmacokinetics, and network analysis to explore active components of BuShao Tiaozhi Capsule on hyperlipidemia","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41522-024-00599-1","article-title":"Role of intestinal testosterone-degrading bacteria and 3\/17\u03b2-HSD in the pathogenesis of testosterone deficiency-induced hyperlipidemia in males","volume":"10","author":"Tao","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0392","DOI":"10.1128\/mBio.02392-17","article-title":"Structural alteration of Gut Microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial","volume":"9","author":"Tong","year":"2018","journal-title":"mBio"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1002\/ptr.8326","article-title":"Gardenia jasminoides ellis. Polysaccharides alleviated cholestatic liver injury by increasing the production of butyric acid and FXR activation","volume":"38","author":"Wang","year":"","journal-title":"Phytother. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12951-024-02807-8","article-title":"Multi-omics analysis of Au@Pt nanozyme for the modulation of glucose and lipid metabolism","volume":"22","author":"Wang","year":"","journal-title":"J. Nanobiotechnology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2228045","DOI":"10.1080\/19490976.2023.2228045","article-title":"Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/s41401-024-01317-5","article-title":"Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E-deficient mice","volume":"45","author":"Xu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9750","DOI":"10.1039\/d4fo02312a","article-title":"Sulfonation metabolism in the gut microbiota is the main metabolic pathway of cholesterol in hypercholesterolemic mice","volume":"15","author":"Yan","year":"2024","journal-title":"Food Funct."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7128230","DOI":"10.1155\/2022\/7128230","article-title":"Guanxinning tablet attenuates coronary atherosclerosis via regulating the gut Microbiota and their metabolites in Tibetan minipigs induced by a high-fat diet","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"119376","DOI":"10.1016\/j.jep.2025.119376","article-title":"Total saponins from Panax japonicus reduced lipid deposition and inflammation in hepatocyte via PHD2 and hepatic macrophage-derived exosomal miR-463-5p","volume":"342","author":"Yang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.bbalip.2018.06.003","article-title":"EP4 emerges as a novel regulator of bile acid synthesis and its activation protects against hypercholesterolemia","volume":"1863","author":"Ying","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B52","doi-asserted-by":"publisher","first-page":"116639","DOI":"10.1016\/j.bcp.2024.116639","article-title":"Scopoletin ameliorates hyperlipidemia and hepatic steatosis via AMPK, Nrf2\/HO-1 and NF-\u03baB signaling pathways","volume":"231","author":"Zhang","year":"","journal-title":"Biochem. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1021\/acs.jafc.4c09270","article-title":"Oleanolic acid alleviates hyperuricemia via Gut Microbiota control the integrity of Gut barrier and the expressions of urate transporter in mice","volume":"73","author":"Zhang","year":"","journal-title":"J. Agric. Food Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1528250","DOI":"10.3389\/fphar.2025.1528250","article-title":"Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice","volume":"16","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2447814","DOI":"10.1080\/19490976.2024.2447814","article-title":"Hypoglycemic effect of C. butyricum-pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus","volume":"17","author":"Zhou","year":"2025","journal-title":"Gut Microbes"},{"key":"B56","doi-asserted-by":"publisher","first-page":"116805","DOI":"10.1016\/j.jep.2023.116805","article-title":"Study on the mechanism of Orthosiphon aristatus (Blume) Miq. in the treatment of hyperuricemia by microbiome combined with metabonomics","volume":"317","author":"Zhu","year":"2023","journal-title":"J. Ethnopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1754769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:38:08Z","timestamp":1774593488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1754769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":56,"alternative-id":["10.3389\/fphar.2026.1754769"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1754769","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1754769"}}